Heterogeneity of alpha 2-adrenoceptors in human and rat myometrium and differential expression during pregnancy

British Journal of Pharmacology
R Bouet-AlardC Legrand

Abstract

1. The aim of this study was first, to characterize alpha 2-adrenoceptor subtypes in human and rat pregnant myometrium and second, to investigate the possibility of a differential expression of the putative subtypes according to the stage of pregnancy. 2. In both species, specific [3H]-rauwolscine binding was inhibited by five different compounds with an order of affinity characteristic of the one described for alpha 2-adrenoceptors (yohimbine > or = clonidine > noradrenaline > phenylephrine > propranolol). Binding affinities (pKi) for the compounds tested were, in human and rat, respectively: 7.63 and 8.93 for yohimbine, 6.91 and 8.71 for clonidine, 6.23 and 6.09 for noradrenaline, 5.37 and 5.73 for phenylephrine, 4.64 and 4.72 for propranolol. 3. By use of non-linear iterative curve fitting procedures and by fitting the data to a two-site model, analysis of [3H]-rauwolscine inhibition binding curves performed in the presence of oxymetazoline (alpha 2A-selective), ARC239, prazosin or chlorpromazine (alpha 2B- and alpha 2C-selective) indicated that pregnant human and rat myometrium contain at least two pharmacologically distinct alpha 2-adrenoceptor subtypes (alpha 2A, alpha 2B and/or alpha 2C). RNA blot analysis with probes sp...Continue Reading

References

Nov 1, 1992·Brain Research. Molecular Brain Research·M PeräläM Scheinin
Feb 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·C S FlordellisH Gavras
Apr 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·D W ZengK R Lynch
Jul 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·J W LomasneyR J Lefkowitz
Sep 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·J W ReganB K Kobilka
Oct 29, 1985·European Journal of Pharmacology·J P Maltier, C Legrand
Jan 1, 1986·Journal of Reproduction and Fertility·C Legrand, J P Maltier
Feb 1, 1973·Analytical Biochemistry·G R Schacterle, R L Pollack
Jul 15, 1983·American Journal of Obstetrics and Gynecology·S P BottariG Vauquelin
Dec 17, 1981·European Journal of Pharmacology·B D Perry, D C U'Prichard
Jun 1, 1993·Hypertension·D E HandyH Gavras
Aug 15, 1993·European Journal of Pharmacology·A MarjamäkiM Scheinin
Jan 1, 1993·Gynecologic and Obstetric Investigation·L O DahleG Rydén

❮ Previous
Next ❯

Citations

Mar 30, 2005·International Journal of Obstetric Anesthesia·A T SiaG S Yeo
May 30, 2013·Indian Journal of Pharmacology·Işil ÖcalIsmail Günay
May 20, 2009·European Journal of Pharmacology·Adrienn GálRóbert Gáspár
Sep 1, 2001·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·B Civantos Calzada, A Aleixandre de Artiñano
Jun 16, 2016·Reproductive Biology and Endocrinology : RB&E·Judit Hajagos-TóthRóbert Gáspár
Oct 21, 2000·Endocrine Reviews· Challis JRGS J Lye
Oct 2, 1998·The American Journal of Physiology·J J McDougallD A Hart

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here